Financials
Financial year 2025
MEDIXAN from Beersel, company number BE0889137236, closed financial year 2025 with a result of € 81,769 after tax. For that financial year MEDIXAN recorded a gross margin of € 225,795 and equity of € 323,083. Compared with financial year 2024, the result moved from € 35,781 to € 81,769. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 323,083
▲ 33% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 81,769
▲ 129% vs 2024
Profit after tax over the fiscal year.
€ 204,157
▼ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 885 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 3,945
▼ 57% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,321
▲ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,855
▲ 60% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 49,060 | € 117,207 | € 149,069 | € 225,795 | ▲ 51% |
| Profit after taxes | € 24,635 | € 72,517 | € 35,781 | € 81,769 | ▲ 129% |
| Equity | € 135,561 | € 207,278 | € 242,200 | € 323,083 | ▲ 33% |
| Total debts | € 52,393 | € 31,399 | € 59,491 | € 55,718 | ▼ 6% |
| Cash | € 122,234 | € 166,663 | € 233,394 | € 204,157 | ▼ 13% |
| Retained profit | € 123,161 | € 194,878 | € 227,940 | € 308,823 | ▲ 35% |
| Dividend | € 800 | € 800 | € 859 | € 885 | ▲ 3% |
| Bank debt | € 18,386 | € 7,388 | € 0 | € 0 | |
| Balance sheet total | € 187,954 | € 238,677 | € 301,691 | € 378,801 | ▲ 26% |
Key figures of MEDIXAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about MEDIXAN the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MEDIXAN?
What happened at MEDIXAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 81,769 (▲ 129% vs 2024). Source: NBB ↗
- New establishment in Beersel. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 24,635 profit in 2022 to € 81,769 profit in 2025.
Paid € 108,410 in corporate taxes since 2022.
Best year ever: 2025, with € 81,769 profit.
Paid out € 3,344 in dividends to the owners in total.
Management
Behind MEDIXAN is Philippe Lothaire.
Directors
According to the 2025 annual accounts
Philippe Lothaire
Director
Establishments
Establishment units
Physical locations of this company
Nijsberglaan 32
1652 Beersel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Philippe LOTHAIRE(oprichter) 100%
Details
- Company number
- 0889.137.236
- VAT number
- BE 0889.137.236
- Registered office
- Nijsberglaan 32, 1652 Beersel
- Names & denominations
- MEDIXAN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 April 2007
- Peppol
- Active · Active since 14 Jul 2025